Back

Impact of staged versus one-time multivessel percutaneous ntervention in ST-elevation myocardial infarction

29 August 2016 (16:03 - 16:10)
Organised by:
Congress Presentation Part of: Coronary revascularisation: how and how much Infarction acute phase STEMI ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Mohammed Makkiya

Albert Einstein Medical Center, The Bronx (United States of America)

6 More presentations in this session

Presentation thumbnail
Routine invasive versus selective invasive strategies for non-st-elevation acute coronary syndrome: an updated meta-analysis of randomised trials
Associate Professor A. Bavry (Gainesville, US)
Abstract Slides
Presentation thumbnail
Differential impact of incomplete revascularization as assessed by residual SYNTAX score on long-term mortality in patients with STEMI versus NSTEMI: a propensity-matched analysis
Doctor D. Milasinovic (Belgrade, RS)
Abstract Slides
Presentation thumbnail
Complete or incomplete coronary revascularization in ACS patients with multivessel coronary disease. One year outcomes according to clinical presentation from the real life Bleemacs registry
Doctor C. Moretti (Chivasso, IT)
Abstract Slides
Presentation thumbnail
Culprit vessel-only vs. multivessel percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction and multivessel disease: results from an 8-year prospective registry
Doctor R. GONZALEZ FERREIRO (Vigo, ES)
Abstract
Presentation thumbnail
Transradial percutaneous coronary intervention could reduce access site complications in STEMI patients requiring intra-aortic balloon pumping support
Mr K. Horie (Sendai, JP)
Abstract Slides

Access the full session

Session thumbnail
Coronary revascularisation: how and how much

The Event

Event poster

ESC Congress 2016

29 August 2016 16:03 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources